Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 137 | 120 | 122 | 147 | 1,107 |
| Accounts receivable | 1,150 | 611 | -1,524 | 1,911 | -871 |
| Other Working Capital | 2,325 | -556 | 718 | 1,146 | -227 |
| Other Operating Activity | -4,218 | -2,148 | -168 | -4,917 | -3,519 |
| Operating Cash Flow | $-606 | $-1,973 | $-852 | $-1,713 | $-3,509 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | 0 | -22 | 0 | -745 | N/A |
| Sale Of Investment | N/A | N/A | 0 | 443 | 0 |
| Other Investing Activity | 738 | 0 | 0 | 32 | 0 |
| Investing Cash Flow | $738 | $-22 | $0 | $-270 | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 16 | 287 | N/A | N/A | N/A |
| Debt Repayment | -15 | -15 | -25 | -55 | -55 |
| Common Stock Issued | 1,843 | 296 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 12 |
| Financing Cash Flow | $1,845 | $569 | $-25 | $-55 | $-43 |
| Beginning Cash Position | 1,330 | 2,757 | 3,634 | 5,671 | 9,223 |
| End Cash Position | 3,307 | 1,330 | 2,757 | 3,634 | 5,671 |
| Net Cash Flow | $1,976 | $-1,427 | $-877 | $-2,037 | $-3,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -606 | -1,973 | -852 | -1,713 | -3,509 |
| Free Cash Flow | -606 | -1,973 | -852 | -1,713 | -3,509 |